Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,020,913
+$1,169,757 QoQ
Shares Held
7,521
-11.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#1,315
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Qtron Investments LLC holds $33,905,175 across 13 Drug Manufacturers - General names. LLY ranks #1 (26.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,521 | $9,020,913 | |
| 2 | JNJ |
Johnson & Johnson
|
21,897 | $5,561,181 | |
| 3 | ABBV |
AbbVie Inc.
|
17,841 | $4,489,509 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,088 | $2,581,308 | |
| 5 | AMGN |
Amgen Inc
|
6,469 | $2,342,554 | |
| 6 | AZN |
Astrazeneca PLC
|
11,190 | $2,121,847 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,328 | $1,689,879 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,413 | $1,568,258 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,020,913 | 7,521 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,851,156 | 8,536 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,171,319 | 8,534 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,978,398 | 9,146 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,307,314 | 9,374 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,120,347 | 9,832 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,952,632 | 9,006 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,390,737 | 9,471 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,827,455 | 9,750 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,074,768 | 9,094 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,806,175 | 8,245 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,563,456 | 8,496 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,727,922 | 7,949 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,384,708 | 6,944 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,928,183 | 8,004 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,479,124 | 7,667 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,637,935 | 8,136 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,414,381 | 4,939 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,364,250 | 4,939 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $1,141,155 | 4,939 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,133,599 | 4,939 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $983,233 | 5,263 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,224,258 | 7,251 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,073,293 | 7,251 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,190,469 | 7,251 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,013,765 | 7,308 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||